EastWest Stock Today

Equity ratings for EastWest Bioscience are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of January 2023 and ending today, the 7th of February 2023. Click here to learn more.
EastWest Bioscience cannot be verified against its exchange. It appears that EastWest Bioscience is not available for investing at the moment. Please verify the symbol is currently traded on TSX Venture Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

EastWest Bioscience Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. EastWest Bioscience's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding EastWest Bioscience or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Macroaxis Advice
The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of EastWest Bioscience's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
EastWest Bioscience (EAST) is traded on TSX Venture Exchange in Canada and employs 4 people. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.52 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate EastWest Bioscience's market, we take the total number of its shares issued and multiply it by EastWest Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. EastWest Bioscience operates under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 100.66 M outstanding shares of which 59.5 K shares are currently shorted by private and institutional investors with about 0.33 days to cover all short positions. EastWest Bioscience has accumulated about 266.17 K in cash with (688.47 K) of positive cash flow from operations.
Check EastWest Bioscience Probability Of Bankruptcy

EastWest Stock Against Markets

Picking the right benchmark for EastWest Bioscience stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in EastWest Bioscience stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for EastWest Bioscience is critical whether you are bullish or bearish towards EastWest Bioscience at a given time.

Try Other Stock Suggestions

EastWest Bioscience Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with EastWest Bioscience stock to make a market-neutral strategy. Peer analysis of EastWest Bioscience could also be used in its relative valuation, which is a method of valuing EastWest Bioscience by comparing valuation metrics with similar companies.
California NanotechnologiesSkychain TechnologiesLeons FurnitureSlate Office REITWELL Health TechnologiesQuorum InformationEvertz TechnologiesOcumetics Technology CorpAmerican AirlinesAlcoa CorpApple IncBest BuyCitigroupSentinelOneCVS Health Corp
 Risk & Return  Correlation

EastWest Bioscience Corporate Management

Elected by the shareholders, the EastWest Bioscience's board of directors comprises two types of representatives: EastWest Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EastWest. The board's role is to monitor EastWest Bioscience's management team and ensure that shareholders' interests are well served. EastWest Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EastWest Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michael Buchecker - Marketing MangProfile
Scott LLB - SecProfile
Rodney Gelineau - CEO, CoFounderProfile
Ciska Asriel - COO CoFounderProfile

Invested in EastWest Bioscience?

The danger of trading EastWest Bioscience is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of EastWest Bioscience is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than EastWest Bioscience. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile EastWest Bioscience is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Investing Opportunities. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Tools for EastWest Stock

When running EastWest Bioscience price analysis, check to measure EastWest Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EastWest Bioscience is operating at the current time. Most of EastWest Bioscience's value examination focuses on studying past and present price action to predict the probability of EastWest Bioscience's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move EastWest Bioscience's price. Additionally, you may evaluate how the addition of EastWest Bioscience to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
CEO Directory
Screen CEOs from public companies around the world
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities